Study evaluating standards in the diagnosis and treatment of Multiple active primary cancers (MAPC)
Latest Information Update: 10 Jul 2021
Price :
$35 *
At a glance
- Drugs Crizotinib (Primary) ; Gefitinib (Primary) ; Lapatinib (Primary) ; Antineoplastics
- Indications Advanced breast cancer; Breast cancer; Lung cancer
- Focus Therapeutic Use
- 10 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology